What To Do When Parkinson’s Medication Stops Working?

Parkinson’s disease is a progressive neurological disorder that affects millions of people worldwide. While there is no cure for Parkinson’s, various medications can help manage its symptoms and improve the quality of life for those living with the condition. However, over time, individuals with Parkinson’s may experience a disheartening reality: their medications no longer provide the same level of relief they once did. This phenomenon is known as “medication wearing off” or “motor fluctuations,” and it can be challenging to navigate.

Source

In this article, we will explore what to do when Parkinson’s medication stops working and discuss the strategies and solutions available to manage this complex issue.

Understanding Parkinson’s Medication and Its Mechanisms

Before delving into the strategies for dealing with medication wearing off, it is essential to understand the types of medications commonly used to manage Parkinson’s disease and how they work.

1. Levodopa:

Levodopa, also known as L-dopa, is a cornerstone medication in the treatment of Parkinson’s disease. It plays a vital role in managing the motor symptoms associated with the condition. Here’s a more detailed explanation of how levodopa works:

Levodopa is a precursor to dopamine, a neurotransmitter that is deficient in Parkinson’s disease. In the brain, dopamine is essential for regulating movement and controlling muscle coordination. However, dopamine itself cannot be administered as a medication because it cannot cross the blood-brain barrier effectively.

Levodopa, on the other hand, can cross the blood-brain barrier and is readily converted into dopamine in the brain. Once in the brain, levodopa is transformed into dopamine by enzymes known as aromatic L-amino acid decarboxylase (AADC).

This conversion process replenishes the depleted dopamine levels, leading to a significant improvement in motor symptoms like tremors, rigidity, and slowness of movement.

However, as Parkinson’s disease progresses, the brain’s ability to convert levodopa into dopamine becomes less efficient, and this is one of the factors contributing to the wearing-off phenomenon as mentioned earlier. Adjusting levodopa dosage and combining it with other medications are strategies employed to optimize its effectiveness in managing Parkinson’s symptoms over the long term.

2. Dopamine Agonists:

Dopamine agonists are another crucial class of medications used in the treatment of Parkinson’s disease, alongside levodopa. They function differently from levodopa but still target the underlying dopamine deficiency in the brain. Here’s a more detailed explanation of how dopamine agonists work:

Dopamine agonists are drugs that directly stimulate dopamine receptors in the brain. Unlike levodopa, which is a precursor to dopamine, dopamine agonists mimic the effects of dopamine itself. By binding to dopamine receptors, these medications activate the same pathways in the brain that dopamine would, helping to alleviate motor symptoms.

Dopamine agonists come in various forms, including oral tablets, patches, and even injectables. They provide a more sustained release of dopamine-like stimulation compared to levodopa, which can result in smoother and more stable symptom control throughout the day.

One advantage of dopamine agonists is that they can be used as an initial therapy or in combination with levodopa to enhance symptom management.

However, they can also have side effects, including nausea, dizziness, and, in some cases, impulse control disorders. Therefore, the choice of medication and its dosing should be carefully tailored to each individual’s specific needs and tolerances under the guidance of a healthcare professional.

3. MAO-B Inhibitors:

Monoamine oxidase type B (MAO-B) inhibitors are a class of medications commonly used in the treatment of Parkinson’s disease. These drugs work by targeting the enzyme MAO-B, which plays a role in breaking down dopamine in the brain. Here’s a more detailed explanation of how MAO-B inhibitors work:

In Parkinson’s disease, the progressive loss of dopamine-producing neurons leads to a decrease in dopamine levels in the brain. MAO-B is an enzyme responsible for metabolizing dopamine. MAO-B inhibitors, such as rasagiline (Azilect) and selegiline (Eldepryl), work by blocking this enzyme’s activity, thus slowing down the breakdown of dopamine.

By inhibiting MAO-B, these medications help preserve the existing dopamine supply in the brain. This, in turn, can extend the duration of symptom relief and reduce motor fluctuations, providing more stable and consistent control over Parkinson’s symptoms.

MAO-B inhibitors are often used in conjunction with other Parkinson’s medications, such as levodopa, to enhance their effectiveness and prolong their duration of action.

However, like all medications, MAO-B inhibitors can have side effects and potential interactions, so it’s crucial to use them under the guidance of a healthcare professional who can tailor the treatment to the individual’s specific needs and monitor for any adverse effects.

4. COMT Inhibitors:

Catechol-O-methyltransferase (COMT) inhibitors are a class of medications used in the management of Parkinson’s disease, typically as an adjunct to levodopa therapy. These inhibitors work by targeting the COMT enzyme, which plays a role in the breakdown of levodopa. Here’s a more detailed explanation of how COMT inhibitors work:

Levodopa is a crucial medication for alleviating the motor symptoms of Parkinson’s disease. However, a significant portion of levodopa is metabolized before it can reach the brain’s dopamine-producing neurons. COMT is one of the enzymes responsible for this metabolism.

COMT inhibitors, such as entacapone (Comtan), tolcapone (Tasmar), and opicapone (Ongentys), work by blocking the action of the COMT enzyme. By inhibiting COMT, these medications extend the duration of levodopa’s effectiveness, as more of the levodopa reaches the brain and is converted into dopamine.

This prolonged action can lead to smoother and more consistent control of motor symptoms, reducing the “off” periods that people with Parkinson’s often experience as their medication wears off.

However, it’s crucial to use COMT inhibitors under medical supervision due to potential side effects and interactions, and they are typically prescribed in conjunction with levodopa to optimize their benefits while minimizing risks.

5. Amantadine:

Amantadine is a medication used in the treatment of Parkinson’s disease, primarily to manage motor symptoms and certain complications related to the disease. Its mechanism of action, while not fully understood, involves several key aspects:

1. Dopamine Release: Amantadine is thought to enhance the release of dopamine in the brain, particularly in areas that control movement. This increased dopamine activity can help alleviate motor symptoms such as tremors, rigidity, and bradykinesia (slowness of movement).
2. Glutamate Modulation: Parkinson’s disease disrupts the balance between dopamine and another neurotransmitter called glutamate. Amantadine appears to modulate glutamate activity, reducing its excitatory effects, which can help in managing motor fluctuations.
3. Antiviral Properties: Originally developed as an antiviral drug, amantadine’s precise mechanism in Parkinson’s treatment is not solely related to its antiviral action. However, its unique properties led to its exploration in managing Parkinson’s symptoms.

Amantadine is often used in combination with other Parkinson’s medications, such as levodopa, to provide additional relief and address fluctuations in symptom control. While it can be effective, it may also have side effects, including confusion and hallucinations in some individuals.

As with all Parkinson’s medications, their use should be supervised and adjusted by a healthcare professional to achieve the best balance between symptom management and potential side effects.

6. Anticholinergics:

Anticholinergics are a class of medications sometimes prescribed for the treatment of Parkinson’s disease, particularly in cases where other treatments have proven ineffective. These drugs work by blocking the action of acetylcholine, a neurotransmitter that has an inhibitory effect on dopamine, the neurotransmitter deficient in Parkinson’s.

Here’s a more detailed explanation of how anticholinergics work:

In Parkinson’s disease, there is an imbalance between dopamine and acetylcholine in the brain. The loss of dopamine-producing neurons leads to an excess of acetylcholine, which contributes to motor symptoms like tremors and rigidity. Anticholinergics, such as trihexyphenidyl (Artane) or benztropine (Cogentin), counteract this imbalance by inhibiting the effects of acetylcholine.

By blocking acetylcholine receptors in the brain, anticholinergics help restore a more favorable dopamine-to-acetylcholine ratio. This can lead to a reduction in certain motor symptoms, particularly tremors, and muscle stiffness.

However, the use of anticholinergics in Parkinson’s disease is limited due to potential side effects, which can include cognitive impairment, memory problems, and even hallucinations. Therefore, their use is often reserved for specific situations and carefully monitored by healthcare professionals. In many cases, other medications like levodopa or dopamine agonists are preferred for managing Parkinson’s symptoms due to their more favorable risk-benefit profiles.

7. Apomorphine:

Apomorphine is a unique and potent medication used in the management of advanced Parkinson’s disease, particularly for addressing severe motor fluctuations and “off” episodes when other treatments may be insufficient. Here’s a more comprehensive explanation of how apomorphine works:

Apomorphine belongs to a class of drugs known as dopamine agonists. Unlike oral dopamine agonists, apomorphine is administered through subcutaneous injection or as a continuous infusion using a portable pump. This rapid and direct delivery method allows for a quicker onset of action, making it a valuable rescue therapy for sudden and severe “off” periods.

When apomorphine is injected, it directly stimulates dopamine receptors in the brain, effectively bypassing some of the issues associated with the oral absorption of medications seen in advanced Parkinson’s disease. This leads to rapid relief from motor symptoms such as rigidity, bradykinesia, and tremors, often within just a few minutes.

Apomorphine’s quick-acting nature makes it an essential option for individuals experiencing unpredictable “off” episodes who do not respond well to oral medications. It provides a reliable means to regain mobility and improve overall quality of life in the presence of severe motor fluctuations.

However, it’s important to note that apomorphine is typically reserved for advanced stages of Parkinson’s due to the necessity for subcutaneous administration and the potential for side effects like nausea and low blood pressure. Its use should be carefully managed and prescribed by a healthcare professional experienced in Parkinson’s disease management.

The Challenge of Medication Wearing Off

Parkinson’s medications are generally effective in managing symptoms when individuals start taking them.

Source

However, as the disease progresses, the brain becomes less responsive to these drugs, leading to a phenomenon known as “medication wearing off” or “motor fluctuations.” This means that the periods of symptom relief become shorter and less predictable, and individuals may experience more “off” time, during which their symptoms return.

The Causes of Medication Wearing Off

Several factors contribute to medication wearing off in Parkinson’s disease:

1. Disease Progression: As Parkinson’s advances, the brain’s ability to absorb and utilize dopamine decreases, making the medication less effective over time.
2. Pharmacokinetics: The way the body processes and metabolizes medications can change as the disease progresses, affecting their duration and effectiveness.
3. Medication Tolerance: Over time, the body may become tolerant to the medications, requiring higher doses for the same effect.
4. Non-motor Symptoms: Medications primarily address motor symptoms, but non-motor symptoms such as anxiety, depression, and sleep disturbances can also impact the overall perception of symptom relief.
5. Stress and Lifestyle: Stress, poor nutrition, lack of exercise, and other lifestyle factors can influence how well medications work.

Strategies for Managing Medication Wearing Off

When Parkinson’s medication starts to lose its effectiveness, it can be frustrating and disheartening. However, there are several strategies and solutions that individuals with Parkinson’s can explore in consultation with their healthcare providers:

1. Adjusting Medication Timing:

Adjusting medication timing is a fundamental strategy for managing medication wearing off in Parkinson’s disease, aiming to optimize symptom control throughout the day.

Here’s a more detailed explanation of this strategy:

1. Assessing Medication Duration: Before adjusting timing, it’s crucial to understand how long each dose of medication provides relief. Some Parkinson’s medications have a predictable duration of action, while others may vary between individuals. This assessment guides the adjustment process.
2. Shortening Dosing Intervals: Increasing the frequency of medication doses can help maintain consistent dopamine levels in the brain. For example, if a medication typically lasts four hours, shortening the dosing interval to three hours may reduce “off” periods.
3. Timing with Meals: Levodopa’s absorption can be influenced by food. Taking it on an empty stomach may lead to faster absorption and more consistent symptom control. Conversely, taking it with a high-protein meal can delay absorption, potentially leading to “off” periods.
4. Nighttime Medication: Some individuals experience significant “off” periods upon waking. Taking a dose of levodopa or another appropriate medication before bedtime can help alleviate morning stiffness and enhance overall symptom control.
5. Continuous-Release Formulations: Extended-release or controlled-release formulations of medications can provide more sustained symptom relief, reducing the need for frequent dosing adjustments.
6. Alarm Reminders: Setting alarms or reminders to take medications at precise intervals can help maintain a consistent schedule, ensuring timely relief and minimizing “off” periods.
7. Communication with Healthcare Provider: It’s essential to work closely with a neurologist or movement disorder specialist to fine-tune medication timing. They can assess individual responses, make necessary adjustments, and monitor for side effects.
8. Keep a Medication Diary: Keeping a daily journal of medication times, symptoms, and their severity can provide valuable insights for both individuals with Parkinson’s and their healthcare providers. This diary can help identify patterns and guide timing adjustments.

Adjusting medication timing is a dynamic process that requires careful observation and collaboration with healthcare professionals. The goal is to find a personalized dosing schedule that minimizes “off” periods while managing potential side effects and ensuring the most effective symptom control throughout the day.

2. Changing Medication Formulation:

Changing medication formulation is a strategy employed to combat medication wearing off in Parkinson’s disease. It involves shifting from immediate-release medications to extended-release or controlled-release formulations.

These alternative formulations release the medication gradually over a more extended period, resulting in more sustained symptom control. For example, converting from immediate-release levodopa to an extended-release version can help reduce the fluctuations between “on” and “off” periods, providing a smoother and more predictable response to the medication.

However, any changes in medication formulation should be made under the guidance of a healthcare professional to ensure safety and efficacy while minimizing potential side effects.

3. Combination Therapy:

Combination therapy involves the simultaneous use of multiple medications to manage Parkinson’s symptoms more effectively. Typically, it combines levodopa, the primary medication, with other classes of drugs like dopamine agonists, MAO-B inhibitors, or COMT inhibitors.

This strategy aims to address the complexity of Parkinson’s disease by targeting different aspects of its pathophysiology. By using multiple medications, it can enhance overall symptom control, extend the duration of relief, and reduce motor fluctuations.

However, this approach should be carefully managed by healthcare professionals to strike the right balance between maximizing benefits and minimizing potential side effects or drug interactions.

4. Continuous Dopaminergic Stimulation:

Continuous dopaminergic stimulation is a strategy employed in advanced Parkinson’s disease to maintain stable dopamine levels in the brain and reduce motor fluctuations. It involves the use of drug delivery systems like duodenal pumps or subcutaneous infusion of apomorphine.

These methods provide a continuous and controlled supply of medication, ensuring more consistent symptom relief throughout the day. By avoiding the peaks and valleys associated with traditional oral medication dosing, this strategy can significantly reduce the “off” periods and enhance the overall quality of life for individuals with Parkinson’s disease.

However, it requires careful monitoring and supervision by healthcare professionals due to potential complications and side effects.

5. Adjunctive Therapies:

Adjunctive therapies are complementary treatments used alongside medication to manage both motor and non-motor symptoms in Parkinson’s disease. These therapies include physical therapy, occupational therapy, speech therapy, and psychotherapy.

They aim to improve mobility, balance, speech, and emotional well-being. Physical therapy, for instance, helps maintain and enhance muscle strength and flexibility. Occupational therapy aids in daily living activities, while speech therapy addresses speech and swallowing difficulties.

Psychotherapy can assist in coping with the emotional challenges of the disease. These therapies can significantly enhance the overall quality of life for individuals with Parkinson’s by addressing the multifaceted nature of the condition and promoting functional independence.

6. Diet and Nutrition:

Diet and nutrition play a crucial role in managing medication wearing off in Parkinson’s disease. Specifically, dietary choices can impact the absorption and effectiveness of medications. To optimize treatment, individuals with Parkinson’s often need to consider factors like the timing of medication relative to meals, protein intake, and balanced nutrition.

For example, taking levodopa on an empty stomach can enhance absorption, while protein-rich meals may delay it. A carefully planned diet can help minimize the risk of interactions and fluctuations in symptom control, ensuring that medications work optimally and reducing the impact of “off” periods. Consulting with a registered dietitian or nutritionist can provide tailored guidance for each individual’s needs.

7. Exercise and Physical Activity:

Regular exercise and physical activity are essential strategies for managing medication wearing off in Parkinson’s disease. Exercise can enhance muscle strength, flexibility, and balance, thereby improving overall mobility and reducing the impact of motor fluctuations. Aerobic activities like walking, swimming, or cycling can also boost mood and energy levels.

Moreover, exercise has been shown to have neuroprotective effects, potentially slowing the progression of the disease. Engaging in a consistent exercise routine, ideally under the guidance of a physical therapist or trainer familiar with Parkinson’s, can significantly improve the effectiveness of medications and help individuals maintain their independence and quality of life.

8. Stress Management:

Stress management is a critical component of coping with medication wearing off in Parkinson’s disease. Stress can exacerbate motor symptoms and impact medication effectiveness. Techniques such as mindfulness, yoga, meditation, and relaxation exercises can help individuals reduce stress levels and enhance their overall well-being.

Additionally, support groups and counseling can provide emotional support and coping strategies for dealing with the challenges of Parkinson’s disease, which, in turn, can indirectly improve symptom control.

By addressing stress through these strategies, individuals with Parkinson’s can better manage their condition and optimize the effectiveness of their medications, ultimately leading to a higher quality of life.

9. Sleep Management:

Sleep management is a crucial strategy in combating medication wearing off in Parkinson’s disease. Sleep disturbances, such as insomnia or frequent awakenings, can disrupt medication schedules and exacerbate motor symptoms.

Healthcare providers may recommend improving sleep hygiene practices, including maintaining a regular sleep schedule, creating a comfortable sleep environment, and avoiding stimulating activities close to bedtime. In some cases, medications to address sleep disturbances or specific interventions for conditions like restless legs syndrome may be necessary.

Quality sleep not only enhances medication effectiveness but also contributes to overall well-being, as it promotes physical and mental health, reduces stress, and supports better symptom control throughout the day.

10. Surgical Options:

Surgical options are considered in advanced cases of Parkinson’s disease when medications are no longer effective in managing symptoms. Two prominent surgical interventions are Deep Brain Stimulation (DBS) and Magnetic Resonance-guided Focused Ultrasound (MRgFUS).

DBS involves implanting electrodes in specific brain regions and connecting them to a neurostimulator device to modulate abnormal brain signals. MRgFUS uses focused ultrasound waves to create precise lesions in the brain, targeting areas responsible for motor symptoms.

Both procedures aim to provide long-term symptom relief, reduce medication needs, and improve quality of life. Surgical options should be discussed with a neurologist or movement disorder specialist and considered when medications no longer adequately control symptoms.

Suggested Read:

Ending Parkinson’s once and for all — here’s how

Affiliate Disclaimer: This page contains affiliate links and I earn a commission if you make a purchase through one of the links, at no cost to you. As an Affiliate, I earn from qualifying purchases.

Conclusion

Dealing with Parkinson’s medication wearing off can be challenging, but it’s essential to remember that there are numerous strategies and solutions available. Effective management often involves a combination of medication adjustments, lifestyle changes, and non-pharmacological interventions.

It’s crucial for individuals with Parkinson’s to work closely with their healthcare providers to tailor a personalized treatment plan that addresses their unique needs and challenges. While there is no cure for Parkinson’s disease, with the right approach, people can continue to lead fulfilling lives and manage their symptoms effectively, even when their medications stop working as well as they used to.

Note: This article is for informational purposes only and should not replace professional medical advice. If you suspect you have Parkinson’s disease or any other medical condition, please consult with a healthcare professional.